# Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System

> **NCT03788590** · NA · UNKNOWN · sponsor: **Ningbo Jenscare Biotechnology Co., Ltd.** · enrollment: 133 (estimated)

## Conditions studied

- Severe Aortic Stenosis
- Aortic Regurgitation

## Interventions

- **DEVICE:** Jenscare TAVI

## Key facts

- **NCT ID:** NCT03788590
- **Lead sponsor:** Ningbo Jenscare Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-23
- **Primary completion:** 2021-11-23
- **Final completion:** 2021-12-30
- **Target enrollment:** 133 (ESTIMATED)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03788590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03788590, "Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03788590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*